PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk.
International journal of molecular sciences ·2023 ·13 citas
Pere Rehues, Josefa Girona, Montse Guardiola, Núria Plana, Roberto Scicali, Salvatore Piro, Ovidio Muñiz-Grijalvo, José Luis Díaz-Díaz, Lluís Recasens, Marta Pinyol, Roser Rosales, Yaiza Esteban, Núria Amigó, Lluís Masana, Daiana Ibarretxe, Josep Ribalta
- Tipo de publicación
- Artículo original
- Citas
- 13 (OpenAlex, 16 de octubre de 2026)
- PMID
- 36768645
Ámbito de estudio
- Enfermedad cardiovascular y lípidos
Plataforma analítica
- Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Perfil de lipoproteínas por RMN
Matriz
- Suero o plasma
Relacionado
Biomarcadores
Publicaciones con los mismos biomarcadores
- Title: Human Serum/Plasma Glycoprotein Analysis by 1H-NMR, an Emerging Method of Inflammatory Assessment. 2020 · Journal of clinical medicine · 98 citas
- Characterization of 1H NMR Plasma Glycoproteins as a New Strategy To Identify Inflammatory Patterns in Rheumatoid Arthritis. 2018 · Journal of proteome research · 73 citas
- An in-depth analysis shows a hidden atherogenic lipoprotein profile in non-diabetic chronic kidney disease patients. 2019 · Expert opinion on therapeutic targets · 53 citas
Ver 30 más Ver menos
- Circulating PCSK9 in patients with type 2 diabetes and related metabolic disorders. 2016 · Clinica e investigacion en arteriosclerosis · 45 citas
- Circulating PCSK9 levels and CETP plasma activity are independently associated in patients with metabolic diseases. 2016 · Cardiovascular diabetology · 38 citas
- The novel inflammatory biomarker GlycA and triglyceride-rich lipoproteins are associated with the presence of subclinical myocardial dysfunction in subjects with type 1 diabetes mellitus. 2022 · Cardiovascular diabetology · 26 citas
- GlycA Levels during the Earliest Stages of Rheumatoid Arthritis: Potential Use as a Biomarker of Subclinical Cardiovascular Disease. 2020 · Journal of clinical medicine · 25 citas
- Plasma inducible degrader of the LDLR, soluble low-density lipoprotein receptor, and proprotein convertase subtilisin/kexin type 9 levels as potential biomarkers of familial hypercholesterolemia in children. 2018 · Journal of clinical lipidology · 24 citas
- Lipidomic and metabolomic changes in community-acquired and COVID-19 pneumonia. 2024 · Journal of lipid research · 22 citas
- Glycoprotein Profile Assessed by 1H-NMR as a Global Inflammation Marker in Patients with HIV Infection. A Prospective Study. 2020 · Journal of clinical medicine · 22 citas
- Glycoprotein Profile Measured by a 1H-Nuclear Magnetic Resonance Based on Approach in Patients with Diabetes: A New Robust Method to Assess Inflammation. 2021 · Life (Basel, Switzerland) · 21 citas
- Lipidomics of triglyceride-rich lipoproteins derived from hyperlipidemic patients on inflammation. 2024 · European journal of clinical investigation · 19 citas
- Acute-phase glycoprotein profile responses to different oral macronutrient challenges: Influence of sex, functional hyperandrogenism and obesity. 2021 · Clinical nutrition (Edinburgh, Scotland) · 17 citas
- Bariatric surgery decreases oxidative stress and protein glycosylation in patients with morbid obesity. 2020 · European journal of clinical investigation · 17 citas
- Serum glycoproteins A and B assessed by 1H-NMR in familial hypercholesterolemia. 2021 · Atherosclerosis · 15 citas
- GlycA and GlycB as Inflammatory Markers in Chronic Heart Failure. 2022 · The American journal of cardiology · 12 citas
- Laparoscopic sleeve gastrectomy alters 1H-NMR-measured lipoprotein and glycoprotein profile in patients with severe obesity and nonalcoholic fatty liver disease. 2021 · Scientific reports · 12 citas
- NMR-based metabolomic profiling identifies inflammation and muscle-related metabolites as predictors of incident type 2 diabetes mellitus beyond glucose: The Di@bet.es study. 2023 · Diabetes research and clinical practice · 10 citas
- Cardiac telerehabilitation with long-term follow-up reduces GlycA and improves lipoprotein particle profile: A randomised controlled trial. 2022 · International journal of cardiology · 10 citas
- Different profiles of lipoprotein particles associate various degrees of cardiac involvement in adolescents with morbid obesity. 2022 · Frontiers in pediatrics · 9 citas
- Measurement of Serum N-Glycans in the Assessment of Early Vascular Aging (Arterial Stiffness) in Adults With Type 1 Diabetes. 2022 · Diabetes care · 8 citas
- Increasing the complexity of lipoprotein characterization for cardiovascular risk in type 2 diabetes. 2024 · European journal of clinical investigation · 7 citas
- Gradual Increase in Inflammation-Linked Glycoproteins and a Proatherogenic Lipoprotein Profile in the Early Stages of Psychosis as Characterized by 1H NMR Blood Analysis. 2023 · Journal of proteome research · 6 citas
- Advanced serum lipoprotein and glycoprotein profiling for cardiovascular event prediction in type 2 diabetes mellitus: the LIPOCAT study. 2025 · Cardiovascular diabetology · 5 citas
- ApoC-III proteoforms are associated with better lipid, inflammatory, and glucose profiles independent of total apoC-III. 2024 · Cardiovascular diabetology · 5 citas
- Evolution of Serum Acute-Phase Glycoproteins Assessed by 1H-NMR in HIV Elite Controllers. 2021 · Frontiers in immunology · 5 citas
- Comprehensive analysis of glycoprotein profiles and their association with cardiovascular disease-related microRNAs in rheumatoid arthritis, metabolic disorders, and controls. 2024 · Scientific reports · 3 citas
- Glycoprotein and Lipoprotein Profiles Assessed by 1H-NMR and Its Relation to Ascending Aortic Dilatation in Bicuspid Aortic Valve Disease. 2022 · Journal of clinical medicine · 1 cita
- Impact of icosapent ethyl on serum lipoand glycoprotein profiles assessed by 1H-NMR. A real-world observational study (IPE-NMR). 2026 · Nutrition, metabolism, and cardiovascular diseases
- Cardiovascular risk and metabolomic profile in adolescents: A comparative study between anorexia nervosa, normal weight, and obesity. 2026 · Clinica e investigacion en arteriosclerosis
- Plasma protein glycosylation: a biomarker for predicting metabolic dysfunction-associated steatotic liver disease in inflammatory bowel disease. 2025 · Revista espanola de enfermedades digestivas
- Glycoprotein Determination with NMR Spectroscopy to Evaluate the Effect of Metabolic Surgery over the Proinflammatory State of Patients with Obesity. 2025 · Obesity surgery
- A case of hypocholesterolemia under study. 2023 · Clinica e investigacion en arteriosclerosis